It has been an interesting earnings season for the Medical sector so far. The sector primarily comprises pharma/biotech and medical device companies.
Most of the large drug and biotech companies have already announced their second-quarter results. Most companies beat estimates for earnings and sales. A majority of these drugmakers also raised their guidance for 2023.
This post originally appeared at 24/7 Wall St.